HIV-infected Pregnant Women Who Request HAART From the TRCSPMTCT Clinical Trial
Official title:
The Thai Red Cross AIDS Research Centre
To assess the safety and the efficacy of Highly Active Anti-Retroviral Treatment (HAART) for the Prevention of Mother-To-Child Transmission of HIV (PMTCT)
1. To describe characteristics of HIV-infected pregnant women who request HAART from the Thai Red Cross Society PMTCT (TRCS PMTCT) program 2. To study adverse pregnancy outcomes among HIV-infected pregnant women who receive HAART 3. To study adverse events in infants born to women who receive HAART during pregnancy 4. To evaluate risk factors for HAART-related toxicities and for perinatal HIV transmission 5. To establish the pilot model of care for HIV-infected pregnant women in middle income country ;